MSPRW MSP Recovery, Inc. (NASDAQ) tops gainers 11 Feb 2026: key metrics to watch

MSPRW stock closed at $0.065 on 11 Feb 2026 after an intraday volume spike that made it a top gainer on the NASDAQ. We saw 1,441,000 shares trade versus a 361,859 average, a clear liquidity burst. This piece unpacks why the move happened, the company financials, technical signals, and what Meyka AI’s model forecasts for MSP Recovery, Inc. in the United States market.

MSPRW stock market move and volume

MSPRW stock jumped to $0.065 on the close, up 16,150.00% from the previous close of $0.0004. The trading volume reached 1,441,000 shares, roughly 4.0 times the average. This surge flagged the ticker among NASDAQ top gainers for the session and drove price discovery on a very small market cap name.

MSPRW stock financials and valuation

MSP Recovery, Inc. shows very thin core metrics with revenue per share TTM of $0.01 and net income per share TTM of -$0.57. The company reports negative book value per share at -$0.67 and cash per share of $0.00. Price ratios are distorted; PE is not meaningful and the price to sales is low at about 0.06, reflecting the penny stock price and small market capitalization.

MSPRW stock technicals and trading signals

Technically, MSPRW stock is oversold on multiple signals with RSI at 31.21 and CCI deeply negative at -236.75. MACD is near zero and ADX at 10.42 indicates no clear trend. Bollinger Bands show tight range between $0.02 and $0.10, which suits short-term volatility trading rather than buy-and-hold strategies.

Meyka Grade and forecast for MSPRW stock

Meyka AI rates MSPRW with a score out of 100: 66.69 which translates to a B grade and a HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of $0.05319, implying an -18.16% change versus the current $0.065. Forecasts are model-based projections and not guarantees.

MSPRW stock risks and near-term catalysts

Liquidity and fundamentals drive the main risk profile for MSPRW stock; current ratio 0.01 and large negative working capital highlight short-term stress. The company lacks reported EPS and regular earnings announcements, raising execution risk. Catalysts would include clearer recovery revenue growth or regulatory clarity in Medicare/Medicaid reimbursement recovery programs.

Trading considerations and price targets for MSPRW stock

For traders, MSPRW stock is a high-volatility microcap on NASDAQ in the Healthcare sector in the United States and quoted in USD. We set a conservative 12-month price target of $0.05 and a bull scenario target of $0.10. The conservative target implies -23.08% downside versus the close. Use tight risk controls given the tiny floats and rapid moves.

Final Thoughts

MSPRW stock’s move to $0.065 on 11 Feb 2026 reflects a liquidity-driven top gainer event more than a change in long-term fundamentals. The business provides Medicare and Medicaid recovery services, but financials show negative net income per share at -$0.57, negative book value, and constrained liquidity. Meyka AI’s forecast model projects a yearly price of $0.05319, implying -18.16% versus the current price. Our proprietary grade places MSPRW at 66.69 out of 100 with a B, HOLD recommendation, which factors in sector and benchmark comparisons, financial growth, and market signals. Traders should treat the name as speculative. If new revenue visibility or regulatory clarity arrives, upside could extend to our bull target of $0.10. Forecasts are model-based projections and not guarantees. For updates, check the company site and market filings, and remember this is analysis, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.